Company Filing History:
Years Active: 2008-2011
Title: Marinella G Callow: Innovator in Biomarker Research
Introduction
Marinella G Callow is a prominent inventor based in San Mateo, CA (US). She has made significant contributions to the field of biomarker research, particularly in the diagnosis and treatment of abnormal cell proliferation. With a total of 2 patents, her work has the potential to impact cancer research and therapeutic development.
Latest Patents
Marinella's latest patents include innovative methods for diagnosing abnormal cell proliferation in biological samples. One of her notable inventions, GEF-H1b, focuses on biomarkers, complexes, assays, and therapeutic uses thereof. This invention relates to screening for drugs that inhibit, reduce, or abolish cell growth, especially tumorigenic cell growth, by detecting a phosphovariant isoform of a guanine nucleotide exchange factor biomarker, such as the novel GEF-H1S. This groundbreaking work aims to enhance the understanding and treatment of cancer.
Career Highlights
Marinella G Callow has established herself as a key figure in her field through her work at Sugen Incorporated. Her research has garnered attention for its innovative approach to addressing critical health issues. Her dedication to advancing biomarker research has positioned her as a leader in the scientific community.
Collaborations
Throughout her career, Marinella has collaborated with esteemed colleagues, including Tod R Smeal and Bahija Jallal. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Marinella G Callow's contributions to biomarker research and her innovative patents highlight her role as a significant inventor in the field. Her work continues to pave the way for advancements in cancer diagnosis and treatment.